The ATB0,+ is significantly increased in some cancers (pancreatic, cervical, colon, and estrogen-positive breast cancers); thus [18F]FIMP perhaps has potential for cancer detection via ATB0,+-targeting. This evidence concerns the gene SLC1A5 and breast cancer.